Rydex Health Care Inv (RYHIX)
| Fund Assets | 24.49M |
| Expense Ratio | 1.40% |
| Min. Investment | $2,500 |
| Turnover | 236.00% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 135.04 |
| YTD Return | 10.65% |
| 1-Year Return | 4.92% |
| 5-Year Return | 33.34% |
| 52-Week Low | 113.43 |
| 52-Week High | 136.13 |
| Beta (5Y) | 0.88 |
| Holdings | 128 |
| Inception Date | Apr 17, 1998 |
About RYHIX
Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Health Care Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Health Care Companies that have small to mid-sized capitalizations. The fund also may purchase American Depositary Receipts ("ADRs") to gain exposure to foreign Health Care Companies and U.S. government securities.
Performance
RYHIX had a total return of 4.92% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.27%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
25.08% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 3.60% |
| Johnson & Johnson | JNJ | 3.36% |
| AbbVie Inc. | ABBV | 3.08% |
| UnitedHealth Group Incorporated | UNH | 2.51% |
| Abbott Laboratories | ABT | 2.27% |
| Thermo Fisher Scientific Inc. | TMO | 2.26% |
| Merck & Co., Inc. | MRK | 2.23% |
| Boston Scientific Corporation | BSX | 1.98% |
| Intuitive Surgical, Inc. | ISRG | 1.92% |
| Amgen Inc. | AMGN | 1.87% |